Large patient population, expansion of distribution networks by the key market players, awareness about benefits of 3D printing technology and its adoption across the emerging countries in Asia-Pacific are the factors that drive the growth of the 3D printing medical devices market globally. In addition, growing government investments to enhance the application of 3D printing technology in various industries, including healthcare, is likely to drive the demand of this market. Stringent regulatory process which delay the approval of 3D-printed medical devices along with lack of trained professional are the key factors that may hinder the growth of the market. Demand for organ transplantation along with mergers & acquisitions adopted by several companies to consolidate their market share create growth opportunities.
High cost and lack of process control and understanding are the key market challenges faced by market players.The report segments the 3D printing medical devices on the basis of component, technology and medical devices. On the basis of component, the market is segmented into 3d printing equipment, materials and services & software. The material is further segmented into plastics, metal and metal alloy powders, biomaterials and other materials. On the basis of technology, the market is segmented into photopolymerization, droplet deposition or extrusion-based technologies, laser beam melting electron beam melting and three dimensional printing or adhesion bonding. The photopolymerization is further segmented into digital light processing, stereolithography and two-photon polymerization (2pp). On the basis of medical devices, the market is further segmented into surgical guides, surgical instruments, prosthetics and implants and tissue engineering products. The surgical guides is further segmented into dental guides, craniomaxillofacial guides, and orthopedic guides whereas surgical instruments is further segmented into surgical fasteners, scalpels and retractors. The prosthetics and implants is further segmented into standard implants and custom implants. Tissue engineering products is further segmented into bone & cartilage scaffolds and ligament & tendon scaffolds.
Geographically the market is segmented into regions such as, North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).Key market players included are Stratasys Ltd., 3D Systems Corporation, Materialise NV, Envisiontec GmbH, Eos GmbH Electro Optical Systems, Renishaw PLC., 3T RPD, Ltd., Arcam AB, Concept Laser GmbH and Prodways.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
SIMILAR MARKET STUDIES
Sleep Apnea Diagnostic Systems - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Sleep Apnea Diagnostic Systems - Medical Devices Pipeline Assessment, 2016" provides an overview of Sleep Apnea Diagnostic Systems currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products ...
November 2016 | $2500 | View Details >>
Gens report, Global Brainwave Synchronization Therapy Device Industry Report 2016 provides detailed market and segment level data on the Global and Chinese consumption of Brainwave Synchronization Therapy Device. The report provides historic, forecast and growth patterns by company, country and type/application from 2016 to 2021. This report delivers an extensive overview ...
December 2015 | $2800 | View Details >>
Summary Propel Labs, Inc. (Propel Labs) is a biotechnology instrumentation company that manufactures products for biochemical and biotechnological companies. The companys products include Avalon, co-lase, co-lase filters, cyan ADP co-lase. Propel Labs also designs and develops flow cytometry software and hardware upgrades that provide accurate data reporting and real-time remote monitoring. ...
October 2015 | $250 | View Details >>
Summary Spinal Modulation, Inc. (SMI) is a medical device company. The company develops therapies for chronic intractable leg pain, back and foot pain. Its product Spinal Modulation AxiumTM Neurostimulator System is an intraspinal neuromodulation therapy, which is used for pain management. SMI’s product stimulates the dorsal root ganglion. The company markets ...
July 2014 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research